Phoenix, AZ10 Active Studies

Hidradenitis Suppurativa Clinical Trials in Phoenix, AZ

Find 10 actively recruiting hidradenitis suppurativa clinical trials in Phoenix, AZ. Connect with local research sites and explore new treatment options.

10
Active Trials
6
Sponsors
5,589
Enrolling

Recruiting Hidradenitis Suppurativa Studies in Phoenix

RecruitingPhoenix, AZNCT05889182

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how s...

1,328 participants
AbbVie
View Study Details
RecruitingPhoenix, AZNCT06468228

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under ar...

1,280 participants
AbbVie
View Study Details
RecruitingPhoenix, AZNCT06212999

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment wi...

960 participants
Incyte Corporation
View Study Details
RecruitingPhoenix, AZNCT06855498

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib....

600 participants
Incyte Corporation
View Study Details
RecruitingPhoenix, AZNCT06958211

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa....

450 participants
Incyte Corporation
View Study Details
RecruitingPhoenix, AZNCT06959225

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa....

400 participants
Incyte Corporation
View Study Details
RecruitingPhoenix, AZNCT06685835

A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

The primary purpose of the study is evaluate the effect of brensocatib compared with placebo....

204 participants
Insmed Incorporated
View Study Details
RecruitingPhoenix, AZNCT06993610

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, follow...

180 participants
Zura Bio Inc
View Study Details
RecruitingPhoenix, AZNCT06956235

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

This is a phase 2b randomized, double-blind, placebo-controlled study of the safety and efficacy of tulisokibart in participants with moderate to severe hidradenitis suppurativa. The primary hypothesi...

147 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingPhoenix, AZNCT06921850

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

The purpose of the study is to assess the PK of bimekizumab following subcutaneous (sc) administration in study participants with moderate to severe hidradenitis suppurativa (HS)...

40 participants
UCB Biopharma SRL
View Study Details

About Hidradenitis Suppurativa Clinical Trials in Phoenix

Hidradenitis suppurativa is a chronic skin condition causing painful lumps under the skin, typically in areas where skin rubs together. It can lead to tunnels under the skin and scarring. Treatment includes antibiotics, biologics, and surgical interventions.

There are currently 10 hidradenitis suppurativa clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 5,589 participants. Research is being sponsored by AbbVie, Incyte Corporation, Insmed Incorporated and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hidradenitis Suppurativa Clinical Trials in Phoenix — FAQ

Are there hidradenitis suppurativa clinical trials in Phoenix?

Yes, there are 10 hidradenitis suppurativa clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What hidradenitis suppurativa treatments are being tested?

The 10 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for hidradenitis suppurativa.

Data updated March 2, 2026 from ClinicalTrials.gov